Injective has been identified among the altcoins to lead the next bull explosion and is regarded as one of the best altcoins to buy now. The potential bullish trend is supported by several positive factors including the news of a Canary Capital proposal for a Staked Injective Exchange Traded Fund (ETF) with optimistic sentiments for Injective's price prediction with a possibility of hitting $100. Canary Capital's proposal for a Staked Injective ETF signals growing altcoin fund demand. Prospective price surges are further strengthened with the news of Injective's successful EVM testnet launch and entry into mega breakout pumping 12% to $25. Substantial on-chain usage spikes pushed Injective Protocol's INJ surge by 46.78%. Canary Capital's move towards launching a trust for staked Injective ETF and integration of XRP on the Injective network are strong indicators of the coin's bullish trajectory. A significant collaboration with Google Cloud and Deutsche Telekom to drive Web3 adoption is seen as a game-changer in the crypto community. This is alongside the launch of onchain AI agents enabling decentralized infrastructure. Finally, the announcement of Deutsche Telekom subsidiary as a validator for Injective blockchain points to greater institutional trust and potential increased marketplace usage.
Injective Coin News Analytics from Thu, 03 Mar 2022 03:34:04 GMT to Wed, 23 Jul 2025 14:33:00 GMT -
Rating 8
- Innovation 5
- Information 7
- Rumor -6